RGT anti-a bcln 150ML mncln ABO GRP BB
Ended Awarded Last action
- Contract number
- SPE2D326F109D
- Awardee
-
Quidelortho Sales Company, LLC UEI ZFXRG96JMJ39
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,018
Award facts
- Contract value 100% obligated
- $1,018.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Raritan, NJ 08869, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC, a HUBZone-certified joint venture, on May 11, 2026, with a ceiling value of $1,018.08 and ultimate completion date of May 12, 2026, for anti-A blood bank gel reagent (150 mL, minimum clone) under a medical supply vehicle.
Place of performance is Raritan, NJ 08869. The order is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract SPE2D326F109D?
SPE2D326F109D was awarded to Quidelortho Sales Company, LLC by Medical Supply Chain (Troop Support) on May 11, 2026.
How much is contract SPE2D326F109D worth?
The government has obligated $1,018 on SPE2D326F109D.
Is contract SPE2D326F109D an order under another contract?
Yes. SPE2D326F109D is a delivery order under SPE2D018D0005, an indefinite delivery contract.
Was contract SPE2D326F109D competed?
The extent of competition for SPE2D326F109D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award